The Center of Computational Imaging and Personalized Diagnostics (CCIPD) at Case Western Reserve University is involved in various different aspects of developing, evaluating and applying novel quantitative image analysis, computer vision, signal processing, segmentation, multi-modal co-registration tools, pattern recognition, and machine learning tools for disease diagnosis, prognosis, and theragnosis in the context of breast, prostate, head and neck, and brain tumors as well as epilepsy and carotid plaque. Our group is also exploring the utility of these methods in studying correlations of disease markers across multiple scales, modalities, and functionalities -- from gene and protein expression to spectroscopy to digital pathology and to multi-parametric MRI.


Facebook Live Stream with Anant

Latest News:

Thu, 2021-02-25 00:03

Anant Madabhushi, PhD, gave a presentation at the Immuno-Oncology 360° conference.
His talk titled, “Applying a Novel AI Approach to Concluded Clinical Trial Data to Predict Response to Cancer Immunotherapy ”, was part of the “Advancements in IO Imaging“  track held on February 24th. 

The conference is held virtually and spans four days.
Learn more about the conference on the Immuno-Oncology 360° website.

Wed, 2021-02-24 22:59

The Global Engage article, “Machine Learning Advances Diagnostics And Prognostics,” highlights Dr. Anant Madabhushi’s talk at the 7th Digital Pathology and AI Congress on the implications of AI in improving cancer diagnosis and better assessing the value of different cancer therapies. Global Engage is the organizer of the 7th Digital Pathology and AI Congress and an international producer of conferences in the medical sector.

Read the full article on the ...

Mon, 2021-02-15 20:09

Anant Madabhushi, PhD, will be speaking at the Tata Memorial Centre’s XIX Annual Conference, Evidence Based Management of Cancers In India: Technology and Cancer Care - Promise and Reality of the Brave New World.. His talk titled, “Pathomics for Precision Oncology”, will be held on March 7th, 2021, 8:00am - 8:30am EST. 

Tata Memorial Centre has championed Evidence Based Management in oncology in India and has hosted an annual meeting on the topic for 18 years.

Learn more and register to listen to the talk here on the EBM 2021...

Mon, 2021-02-15 20:03

After receiving a nomination to The Pathologist’s 2020 Power List, Anant Madabhushi, PhD, will be speaking alongside other nominees during the virtual event. The event will be held on March 2nd and will provide a multifaceted discussion on the outlook for digital pathology in 2021 and beyond. 
Go to...

Mon, 2021-02-08 13:55

Researchers discover biomarkers to identify lung cancer patients who could be made worse by same drugs that helps many others

CLEVELAND--Researchers at Case Western Reserve University, using artificial intelligence (AI) to analyze simple tissue scans, say they have discovered biomarkers that could tell doctors which lung cancer patients might actually get worse from immunotherapy.
Until recently, researchers and oncologists had placed these lung cancer patients into two broad categories: those who would benefit from immunotherapy, and those who likely would not.
But a...